BEXSON BIOMEDICAL TO PRESENT AT ARROWHEAD PUBLISHERS’ 2ND ANNUAL PSYCHEDELIC THERAPEUTICS & DRUG DEVELOPMENT CONFERENCE

Co-founder and Chief Scientific Officer, Jeffrey Becker, MD, will join top researchers in discussing key issues related to bringing psychedelic therapies to the medical system. SANTA BARBARA, Calif., May 23, 2022 /PRNewswire/ — Bexson Biomedical, Inc., a research-stage company developing…

BEXSON BIOMEDICAL TO PRESENT AT ARROWHEAD PUBLISHERS’ 2ND ANNUAL PSYCHEDELIC THERAPEUTICS & DRUG DEVELOPMENT CONFERENCE

Co-founder and Chief Scientific Officer, Jeffrey Becker, MD, will join top researchers in discussing key issues related to bringing psychedelic therapies to the medical system. SANTA BARBARA, Calif., May 23, 2022 /PRNewswire/ — Bexson Biomedical, Inc., a research-stage company developing…